Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Warner

Showing results (781-790 of 805) with videos related to

Pageof 81
Sort By:
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Pageof 81

Showing results (781-790 of 805) with videos related to

Sort By:
Pageof 81
Scientific Reports|October 17, 2020
Seven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth A Sigworth, Adrianne H Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Cancer Immunology Research|June 28, 2023
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T CellsR Leo Sakemura, Mehrdad Hefazi, Michelle J Cox, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Journal of Thrombosis and Haemostasis : JTH|July 14, 2021
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al.
BMC Cancer|March 23, 2023
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B Johnson, Michael B Atkins, Cassandra Hennessy, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 1, 2022
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Peter Horak, Malachi Griffith, Arpad M Danos, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Lancet Regional Health. Americas|February 23, 2023
Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer ConsortiumToni K Choueiri, Chris Labaki, Ziad Bakouny, et al.
Pageof 81